Form 8-K - Current report:
SEC Accession No. 0001645113-23-000042
Filing Date
2023-06-08
Accepted
2023-06-08 16:12:15
Documents
12
Period of Report
2023-06-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K nvcr-20230607.htm   iXBRL 8-K 56850
  Complete submission text file 0001645113-23-000042.txt   195279

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvcr-20230607.xsd EX-101.SCH 2001
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvcr-20230607_lab.xml EX-101.LAB 24055
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvcr-20230607_pre.xml EX-101.PRE 12579
6 EXTRACTED XBRL INSTANCE DOCUMENT nvcr-20230607_htm.xml XML 10814
Mailing Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF
Business Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF 44 (0)15 3475 6700
NovoCure Ltd (Filer) CIK: 0001645113 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37565 | Film No.: 231002033
SIC: 3841 Surgical & Medical Instruments & Apparatus